A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale

[1]  Joel E Williams,et al.  Improving Hypertension Self-Management With Community Health Coaches , 2015, Health promotion practice.

[2]  Sisira Edirippulige,et al.  Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers , 2014, Int. J. Medical Informatics.

[3]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[4]  V. Patel,et al.  Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial , 2014, The Lancet.

[5]  E. DeLong,et al.  Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial , 2014, BMC Public Health.

[6]  N. Islam,et al.  A community health worker intervention to improve management of hypertension among Filipino Americans in New York and New Jersey: a pilot study. , 2014, Ethnicity & disease.

[7]  Adolfo Rubinstein,et al.  The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. , 2014, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[8]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[9]  N. Wong,et al.  Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). , 2013, The American journal of cardiology.

[10]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[11]  O. Franco,et al.  Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review , 2013, BMC Public Health.

[12]  Robert Dufour,et al.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. , 2013, The Canadian journal of cardiology.

[13]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[14]  Lijing L. Yan,et al.  Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. , 2012, American journal of hypertension.

[15]  R. Dandona,et al.  The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. , 2012, Journal of the American College of Cardiology.

[16]  J. Paul.  BMC public health. , 2012, World health & population.

[17]  M. Hill,et al.  Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers , 2011, Circulation. Cardiovascular quality and outcomes.

[18]  Rajeev Gupta,et al.  Interventions for cardiovascular disease prevention. , 2011, Cardiology clinics.

[19]  W. Elliott.  Community-Based Interventions to Promote Blood Pressure Control in a Developing Country: A Cluster Randomized Trial , 2010 .

[20]  S. MacMahon,et al.  Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. , 2009, American heart journal.

[21]  M. Woodward,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002 , 2008, Circulation.

[22]  Stephen Jan,et al.  Global inequalities in access to cardiovascular health care: our greatest challenge. , 2008, Journal of the American College of Cardiology.

[23]  K. Anand,et al.  Risk factors for non-communicable disease in urban Haryana: a study using the STEPS approach. , 2008, Indian heart journal.

[24]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[25]  X. Rabasseda.  New joint European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. , 2007, Timely topics in medicine. Cardiovascular diseases.

[26]  K. Anand,et al.  Are the urban poor vulnerable to non-communicable diseases? A survey of risk factors for non-communicable diseases in urban slums of Faridabad. , 2007, The National medical journal of India.

[27]  Zuo Chen,et al.  Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults , 2006, Circulation.

[28]  Milton C Weinstein,et al.  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis , 2006, The Lancet.

[29]  Milton C. Weinstein,et al.  Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level , 2005, Circulation.

[30]  Lisa Hartling,et al.  Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.

[31]  D. Beevers,et al.  The atlas of heart disease and stroke , 2005, Journal of Human Hypertension.

[32]  Evangelos Evangelou,et al.  Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). , 2005, Contemporary clinical trials.

[33]  E. Balas,et al.  Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success , 2005, BMJ : British Medical Journal.

[34]  G. E. Who,et al.  Preventing chronic diseases: a vital investment , 2005 .

[35]  George A. Mensah,et al.  The atlas of heart disease and stroke , 2005 .

[36]  Amalia Waxman,et al.  Who Global Strategy on Diet, Physical Activity and Health * , 2004, Food and nutrition bulletin.

[37]  K. Reddy,et al.  Cardiovascular disease in non-Western countries. , 2004, The New England journal of medicine.

[38]  Gösta Samuelson,et al.  Global strategy on diet, physical activity and health , 2004 .

[39]  J F Potter,et al.  Extract from : , 2009 .

[40]  S. Priori,et al.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.

[41]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[42]  Anthony Rodgers,et al.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk , 2003, The Lancet.

[43]  K. Reddy,et al.  Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action , 2002, Public Health Nutrition.

[44]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[45]  D. Rennie,et al.  CONSORT statement on the reporting standards of clinical trials , 1997 .

[46]  N. Wald,et al.  CONSORT statement on the reporting standards in clinical trials. Recommendations are inappropriate for trial reports. , 1997, BMJ.

[47]  J. Cutler,et al.  Randomized trials of sodium reduction: an overview. , 1997, The American journal of clinical nutrition.

[48]  L. Beilin.  Non-pharmacological management of hypertension: optimal strategies for reducing cardiovascular risk. , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[49]  J. Broderick,et al.  Heart disease and stroke. , 1993, Heart disease and stroke : a journal for primary care physicians.

[50]  P. Elliott,et al.  An Overview of Randomized Trials of Sodium Reduction and Blood Pressure , 1991, Hypertension.

[51]  C. K. Liu,et al.  Cardiovascular diseases in China. , 1962, The American journal of cardiology.